Skip to content
Clinical Trials – home
VerifiedinfoResponsive

Universita' Degli Studi Di Verona

Italy Piazzale Aristide Stefani 1, 37126 Verona, Italy

  • 105 trials recruiting
  • Non-small cell lung cancer · Cystic fibrosis · Obesity
  • Adults and children

About Specializations

Universita' Degli Studi Di Verona in Verona, Italy specialises in clinical trials of conditions such as Non-small cell lung cancer, Cystic fibrosis, Obesity, Acute lymphocytic leukaemia, and other specialisations. This site conducts important research.

Main research areas of the site

Neoplasms and Urologic Oncology

At the Universita' Degli Studi Di Verona, research in neoplasms focuses on cancers such as high-risk localized or locally advanced prostate cancer and acute lymphoblastic leukemia. These studies are designed to assess whether new treatment approaches can improve cancer control and long-term outcomes.

  • Evaluating treatment effectiveness in prostate cancer
  • Improving survival outcomes in infant acute lymphoblastic leukemia
  • Supporting better cancer care through new therapeutic strategies

This work reflects a strong clinical focus on testing therapies that may offer more effective options for patients with difficult-to-treat cancers.

Cardiovascular Diseases and Stroke Prevention

Clinical trials in cardiovascular diseases at this site are centered on reducing the risk of ischemic stroke after a recent event such as an acute stroke or high-risk transient ischemic attack. The main goal is to determine whether new antithrombotic treatments can better prevent future strokes while maintaining safety.

  • Preventing recurrent ischemic stroke
  • Studying treatment options after transient ischemic attack
  • Balancing effectiveness with bleeding risk

These studies aim to improve secondary prevention for people at elevated risk of another cerebrovascular event.

Eye Diseases and Pediatric Ophthalmic Care

Research in eye diseases includes studies involving children and adolescents who need ocular surface anesthesia for eye examinations. The purpose is to compare approaches that may make routine ophthalmic care more comfortable and effective for young patients.

  • Improving ocular anesthesia for pediatric eye exams
  • Supporting comfort during ophthalmic procedures
  • Evaluating practical options for everyday clinical use

This area highlights a patient-friendly focus on making pediatric eye care easier while maintaining clinical effectiveness.

Nutritional and Metabolic Diseases and Weight Management

Trials in nutritional and metabolic diseases at the Verona site address obesity and overweight in adolescents with related health conditions. The research is aimed at assessing whether new therapies can help improve weight control and associated health outcomes.

  • Managing obesity in adolescents
  • Addressing overweight with weight-related comorbidities
  • Testing treatments that may support healthier metabolic outcomes

These studies are part of a broader effort to find better options for young people affected by excess weight and its complications.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Piazzale Aristide Stefani 137126 VeronaItaly
Recruiting now
105 trials
Conditions studied
171
Partner status
Verified

More sites in VeronaItaly

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

234 clinical trials

Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Bevacizumab
  • Sponsor:Amgen Inc.
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bi 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:ItalyItaly
  • Participants:0–17 years
  • Sponsor:Eli Lilly & Co.
Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bhv-7000
  • Sponsor:Biohaven Therapeutics Ltd.
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Seagen Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Clazakizumab
  • Sponsor:CSL Behring LLC
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Sponsor:Merck Healthcare KGaA
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Ruxolitinib
  • Sponsor:Novartis Pharma AG
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Nipocalimab
  • Sponsor:Janssen Cilag International
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Boehringer Ingelheim Espana S.A.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).